Endospan

Endospan is a privately-held company headquartered in Herzliya (Tel Aviv), Israel, and a pioneer in endovascular repair for aortic arch diseases, including aneurysms and dissections. Endospan's NEXUSTM Aortic Arch Stent Graft System is the first off-the-shelf endovascular system with CE Mark for treating patients diagnosed with ectatic lesions or those near the aortic arch. Endospan’s NEXUS Aortic Arch Stent Graft System is the first and only branched endovascular aortic arch system to receive CE approval. NEXUS is suitable for a wide range of aortic pathologies, including arch aneurysms, thoracic dissections, and PAU, designed to overcome specific challenges posed by the anatomy of the aortic arch.